DOI:

EAPCI Focus on “Hot topics in Interventional Cardiology” at ESC 2016

EAPCI Focus on “Hot topics in Interventional Cardiology” at ESC 2016

This year’s European Society of Cardiology congress in Rome highlights 163 specific topics organised under nine main subject areas organised in themed villages.

The EAPCI has specifically organised Village 2, with the following subthemes: interventions / peripheral circulation / stroke / surgery.

The objectives of these Village 2 presentations are to combine the latest research with case presentations and interactive discussions to provide clear-cut, simple, take-home messages for the practising clinician – something that they can use right away in the daily care of their patients.

There will also be a focus on the Heart Team, with discussions on the expansion of the “Team” beyond interventional cardiologists and cardiac surgeons to all related professionals, including general cardiologists, general practitioners and endocrinologists, etc.

Other topics of interest include: blood thinning following transaortic valve implantation (TAVI); bystander lesions in ST-segment elevation myocardial infarction (STEMI); managing multiple, multi-state diseases; balancing ischaemia management with bleeding risk and translating recommendations into individual care (the 2015 non-STEMI ESC clinical practice guidelines).

In addition, there will be a special session entitled: “Hot topics in Interventional Cardiology”. This will take place on the 30th of August from 14:00 to 15:30, “Helsinki” (Village 2) under the chairmanship of Marco Valgimigli (Bern, Switzerland) and Andreas Baumbach (Bristol, United Kingdom).

In the field of percutaneous valvular interventions, Stephan Windecker (Bern, Switzerland) will discuss whether TAVI will replace surgical aortic valve replacement and Michael Haude, President of the EAPCI (Neuss, Germany), will present transcatheter mitral valve repair and replacement techniques. In the field of coronary interventions, Robert Byrne (Munich, Germany) will present a critical appraisal of the first-generation bioresorbable coronary scaffold devices. Felix Mahfoud (Homburg/Saar, Germany) will update the attendees on renal denervation for the treatment of arterial hypertension.

For more information check out www.escardio.org

NEWS

Save the date! EAPCI General Assembly at ESC Congress

All ESC Associations have aligned their constitutions with ESC Statutes to facilitate internal governance. EAPCI Members are invited to vote on the new EAPCI Constitution during the General Assembly taking place during ESC Congress 2016 in Rome on Sunday 28 August 2016 from 15:00 to 15:30, Passarella, Level 1, ESC Meeting Room 5.

The EAPCI now has more than 7,400 members from 133 countries! Join today and be part of an interactive European interventional cardiology network. EAPCI Membership is free and offers a wide range of benefits.

Mark your calendar! Applications for EAPCI interventional cardiology training and research grants open in September 2016. For more info: www.escardio.org/eapci

Volume 12 Number 6
Aug 20, 2016
Volume 12 Number 6
View full issue


Key metrics

Suggested by Cory

10.4244/EIJ-D-19-00040 Apr 5, 2019
Interventional cardiology 2018: the year in review
Komiyama H et al
free

10.4244/EIJV7I2A29 Jun 30, 2011
EuroPCR 2011: the ongoing challenge of initiatives and innovations
Serruys PW
free

10.4244/EIJV9I12A230 Apr 22, 2014
Innovation: “It’s about the people you have!”
Serruys PW
free

Editorial

10.4244/EIJ-E-24-00064 Jan 6, 2025
Bringing order to chaos. Invasive functional assessment for all patients in the cath lab?
Zimmermann F and Pollio Benvenuto C
free

10.4244/EIJV10I9A175 Jan 22, 2015
Standards of care: The EAPCI, guidelines and consensus documents
Windecker S
free

Original Research

10.4244/EIJ-D-25-00307 Oct 6, 2025
Impact of clinical risk characteristics on the prognostic value of high-risk plaques
Volleberg R et al

Original Research

10.4244/EIJ-D-26-00425 May 20, 2026
A randomised trial of carbon-dioxide flushing to reduce vascular brain injury in patients undergoing TAVI
Khawaja S et al
Trending articles
334.8

State-of-the-Art Review

10.4244/EIJ-D-21-00904 Apr 1, 2022
Antiplatelet therapy after percutaneous coronary intervention
Angiolillo D et al
free
202.75

State-of-the-Art

10.4244/EIJ-D-21-00089 Jun 11, 2021
Intracoronary optical coherence tomography: state of the art and future directions
Ali ZA et al
free
47.45

NEW INNOVATION

10.4244/EIJ-D-15-00467 Feb 20, 2018
Design and principle of operation of the HeartMate PHP (percutaneous heart pump)
Van Mieghem NM et al
free
42.15

State-of-the-Art

10.4244/EIJ-D-25-00896 Apr 6, 2026
Pretreatment with antiplatelet agents in patients undergoing coronary revascularisation
Kaur G et al
free
33.05

State-of-the-Art

10.4244/EIJ-D-25-00874 Jun 1, 2026
TAVI and coronary interventions: indications, technical considerations, and clinical scenarios
Aquino Bruno H et al
free
27.6

Original Research

10.4244/EIJ-D-25-01370 May 21, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
27.6

Original Research

10.4244/EIJ-D-25-01370 Jun 1, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
19.5

Original Research

10.4244/EIJ-D-26-00032 May 15, 2026
Glucocorticoids to reduce permanent pacemaker implantation after TAVI: the GLUCO-TAVI randomised trial
Fuertes-Kenneally L et al
X

PCR
Impact factor: 9.2
2025 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2026)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved